FDA committee to discuss Pfizer's tafamidis

FDA's Peripheral and Central Nervous System Drugs Advisory Committee will meet on May 24 to discuss an NDA from Pfizer Inc. (NYSE:PFE) for tafamidis to treat transthyretin (TTR) familial amyloid polyn...